Jump to content

U.S. allows emergency use of first COVID-19 antibody drug


Recommended Posts

Posted

U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.

The drug is a monoclonal antibody – a widely used class of biotech drugs which in this case is a manufactured copy of an antibody the human body creates to fight infections.

A similar treatment developed by Regeneron Pharmaceuticals Inc was given to U.S. President Donald Trump after he caught the coronavirus in early October. The nation’s top infectious disease expert Dr. Anthony Fauci said it likely contributed to Trump’s recovery.

Regeneron is also seeking an EUA for its dual-antibody against COVID-19.

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...